What are the differences between hydroxyzine and cinnarizine for the prevention and treatment of motion sickness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cinnarizine is More Effective than Hydroxyzine for Motion Sickness Prevention

For motion sickness prevention, cinnarizine at 50 mg is the preferred first-generation antihistamine based on proven efficacy in natural conditions, while hydroxyzine lacks specific evidence for motion sickness and carries significant sedation risks that impair performance. 1, 2

Key Pharmacological Differences

Cinnarizine

  • Mechanism: Reduces vestibular sensitivity by suppressing the vestibulo-ocular reflex, with demonstrated reduction in gain response to oscillations at multiple frequencies 1
  • Proven efficacy: 50 mg cinnarizine improved seasickness symptoms in 69% of subjects versus 31% with placebo (p < 0.01), with 63% vomiting protection 1, 2
  • Dosing: 50 mg is effective; 25 mg shows no significant benefit over placebo 2
  • Side effects: Minimal notable adverse effects even at therapeutic doses 2

Hydroxyzine

  • Mechanism: First-generation antihistamine with antihistaminic, anticholinergic, and antisecretory properties; suppresses subcortical CNS activity 3
  • Motion sickness evidence: No specific studies demonstrate efficacy for motion sickness. The sedative effect may play a role, but second-generation antihistamines (cetirizine, fexofenadine) failed to prevent motion sickness, suggesting central sedation rather than peripheral antihistamine effects may be necessary 4
  • Significant safety concerns:
    • Marked sedation and performance impairment without subjective awareness 5
    • Drivers taking first-generation antihistamines are 1.5 times more likely to cause fatal automobile accidents 5
    • Impaired driving worsens with cellular phone use 5
    • Anticholinergic effects (dry mouth, constipation, urinary retention, narrow-angle glaucoma risk) 5
    • Prolonged plasma half-life causes daytime impairment even with bedtime dosing 5

Clinical Recommendation Algorithm

For motion sickness prevention:

  1. First-line: Cinnarizine 50 mg taken before exposure to motion

    • Proven 69% symptom improvement rate 1
    • Minimal side effects
    • Effective vestibular suppression
  2. Alternative if cinnarizine unavailable: Scopolamine (more effective than cinnarizine but more side effects) 6

  3. Avoid hydroxyzine for motion sickness because:

    • No evidence of efficacy for motion sickness specifically
    • Unacceptable sedation and performance impairment 5
    • Dangerous for activities requiring alertness (driving, operating machinery)
    • Better alternatives exist with proven efficacy

Important Caveats

Hydroxyzine should NOT be used for motion sickness prevention despite being a first-generation antihistamine, because the evidence shows second-generation antihistamines (which lack sedation) fail to prevent motion sickness 4. This suggests the sedative effect—not the antihistamine effect—may be the active component, making hydroxyzine's risk-benefit profile unacceptable when safer alternatives exist.

Special populations requiring caution with hydroxyzine 5:

  • Elderly: Higher risk of falls, fractures, subdural hematomas, cognitive impairment
  • Children: Risk of paradoxical CNS stimulation and impaired learning
  • Pregnancy: Contraindicated in early pregnancy 3
  • Patients with narrow-angle glaucoma, benign prostatic hypertrophy, or cognitive impairment

The Cochrane review confirms that first-generation antihistamines (specifically cinnarizine and dimenhydrinate—NOT hydroxyzine) probably reduce motion sickness under natural conditions (RR 1.81,95% CI 1.23-2.66) but increase sedation risk 7.

References

Research

Effect of cinnarizine in the prevention of seasickness.

Aviation, space, and environmental medicine, 1994

Guideline

the diagnosis and management of rhinitis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2008

Research

INM investigations into drugs for seasickness prophylaxis.

Journal of the Royal Naval Medical Service, 1994

Research

Antihistamines for motion sickness.

The Cochrane database of systematic reviews, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.